参考文献/References:
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.DOI:10.3760/cma.j.cn115791-20210221-00095.
[2] Shields BM,Hicks S,Shepherd MH,et al.Maturity-onset diabetes of the young(MODY):how many cases are we missing?[J].Diabetologia,2010,53(12):2504-2508.DOI:10.1007/s00125-010-1799-4.
[3] Grilli R,Magrini N,Penna A,et al.Practice guidelines developed by specialty societies:the need for a critical appraisal[J].Lancet,2000,355(9198):103-106.DOI:10.1016/S0140-6736(99)02171-6.
[4] 陈耀龙,罗旭飞.临床实践指南的制订方法与步骤[J].中华传染病杂志,2019,37(9):523-526.DOI:10.3760/cma.j.issn.1000-6680.2019.09.003.
[5] Froguel P,Vaxillaire M,Sun F,et al.Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus[J].Nature,1992,356(6365):162-164.DOI:10.1038/356162a0.
[6] Hattersley AT,Turner RC,Permutt MA,et al.Linkage of type 2 diabetes to the glucokinase gene[J].Lancet,1992,339(8805):1307-1310.DOI:10.1016/0140-6736(92)91958-b.
[7] Carlsson A,Shepherd M,Ellard S,et al.Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY:lessons from a 5-year pediatric Swedish national cohort study[J].Diabetes Care,2020,43(1):82-89.DOI:10.2337/dc19-0747.
[8] Delvecchio M,Mozzillo E,Salzano G,et al.Monogenic diabetes accounts for 6.3% of cases referred to 15 italian pediatric diabetes centers during 2007 to 2012[J].J Clin Endocrinol Metab,2017,102(6):1826-1834.DOI:10.1210/jc.2016-2490.
[9] Chakera AJ,Spyer G,Vincent N,et al.The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy:the Atlantic Diabetes in Pregnancy Cohort[J].Diabetes Care,2014,37(5):1230-1236.DOI:10.2337/dc13-2248.
[10] Chakera AJ,Steele AM,Gloyn AL,et al.Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation[J].Diabetes Care,2015,38(7):1383-1392.DOI:10.2337/dc14-2769.
[11] Liang H,Zhang Y,Li M,et al.Recognition of maturity-onset diabetes of the young in China[J].J Diabetes Investig,2021,12(4):501-509.DOI:10.1111/jdi.13378.
[12] Lorini R,Klersy C,d'Annunzio G,et al.Maturity-onset diabetes of the young in children with incidental hyperglycemia:a multicenter Italian study of 172 families[J].Diabetes Care,2009,32(10):1864-1866.DOI:10.2337/dc08-2018.
[13] Feigerlová E,Pruhová S,Dittertová L,et al.Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents[J].Eur J Pediatr,2006,165(7):446-452.DOI:10.1007/s00431-006-0106-3.
[14] Rudland VL,Hinchcliffe M,Pinner J,et al.Identifying glucokinase monogenic diabetes in a multiethnic gestational diabetes mellitus cohort:new pregnancy screening criteria and utility of HbA1c[J].Diabetes Care,2016,39(1):50-52.DOI:10.2337/dc15-1001.
[15] Osbak KK,Colclough K,Saint-Martin C,et al.Update on mutations in glucokinase(GCK),which cause maturity-onset diabetes of the young,permanent neonatal diabetes,and hyperinsulinemic hypoglycemia[J].Hum Mutat,2009,30(11):1512-1526.DOI:10.1002/humu.21110.
[16] Sagen JV,Odili S,Bjørkhaug L,et al.From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation[J].Diabetes,2006,55(6):1713-1722.DOI:10.2337/db05-1513.
[17] Byrne MM,Sturis J,Clément K,et al.Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations[J].J Clin Invest,1994,93(3):1120-1130.DOI:10.1172/JCI117064.
[18] Njølstad PR,Sagen JV,Bjørkhaug L,et al.Permanent neonatal diabetes caused by glucokinase deficiency:inborn error of the glucose-insulin signaling pathway[J].Diabetes,2003,52(11):2854-2860.DOI:10.2337/diabetes.52.11.2854.
[19] Njølstad PR,Søvik O,Cuesta-Muñoz A,et al.Neonatal diabetes mellitus due to complete glucokinase deficiency[J].N Engl J Med,2001,344(21):1588-1592.DOI:10.1056/NEJM200105243442104.
[20] Hattersley AT,Greeley S,Polak M,et al.ISPAD Clinical Practice Consensus Guidelines 2018:the diagnosis and management of monogenic diabetes in children and adolescents[J].Pediatr Diabetes,2018,19 Suppl 27:47-63.DOI:10.1111/pedi.12772.
[21] Weedon MN,Clark VJ,Qian Y,et al.A common haplotype of the glucokinase gene alters fasting glucose and birth weight:association in six studies and population-genetics analyses[J].Am J Hum Genet,2006,79(6):991-1001.DOI:10.1086/509517.
[22] Paré G,Chasman DI,Parker AN,et al.Novel association of HK1 with glycated hemoglobin in a non-diabetic population:a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study[J].PLoS Genet,2008,4(12):e1000312.DOI:10.1371/journal.pgen.1000312.
[23] Gloyn AL,van de Bunt M,Stratton IM,et al.Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia[J].Diabetologia,2009,52(1):172-174.DOI:10.1007/s00125-008-1188-4.
[24] Steele AM,Shields BM,Wensley KJ,et al.Prevalence of vascular complications among patients with glucokinase mutations and prolonged,mild hyperglycemia[J].JAMA,2014,311(3):279-286.DOI:10.1001/jama.2013.283980.
[25] Stride A,Vaxillaire M,Tuomi T,et al.The genetic abnormality in the beta cell determines the response to an oral glucose load[J].Diabetologia,2002,45(3):427-435.DOI:10.1007/s00125-001-0770-9.
[26] Steele AM,Wensley KJ,Ellard S,et al.Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation:observational case control studies[J].PLoS One,2013,8(6):e65326.DOI:10.1371/journal.pone.0065326.
[27] Ming-Qiang Z,Yang-Li D,Ke H,et al.Maturity onset diabetes of the young(MODY)in Chinese children:genes and clinical phenotypes[J].J Pediatr Endocrinol Metab,2019,32(7):759-765.DOI:10.1515/jpem-2018-0446.
[28] Fendler W,Maachowska B,Baranowska-Jazwiecka A,et al.Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes,GCK-MODY[J].Diabet Med,2014,31(7):881-883.DOI:10.1111/dme.12449.
[29] Velho G,Blanché H,Vaxillaire M,et al.Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families[J].Diabetologia,1997,40(2):217-224.DOI:10.1007/s001250050666.
[30] Velho G,Vaxillaire M,Boccio V,et al.Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q[J].Diabetes Care,1996,19(9):915-919.DOI:10.2337/diacare.19.9.915.
[31] Pruhova S,Dusatkova P,Kraml PJ,et al.Chronic mild hyperglycemia in GCK-MODY patients does not increase carotid intima-media thickness[J].Int J Endocrinol,2013,2013:718254.DOI:10.1155/2013/718254.
[32] Franco LF,Szarf G,Dotto RP,et al.Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations[J].Diabetes Res Clin Pract,2021,176:108867.DOI:10.1016/j.diabres.2021.108867.
[33] Schober E,Rami B,Grabert M,et al.Phenotypical aspects of maturity-onset diabetes of the young(MODY diabetes)in comparison with Type 2 diabetes mellitus(T2DM)in children and adolescents:experience from a large multicentre database[J].Diabet Med,2009,26(5):466-473.DOI:10.1111/j.1464-5491.2009.02720.x.
[34] Fu J,Ping F,Wang T,et al.A clinical prediction model to distinguish maturity-onset diabetes of the young from type 1 and type 2 diabetes in the Chinese population[J].Endocr Pract,2021,27(8):776-782.DOI:10.1016/j.eprac.2021.05.002.
[35] Wang X,Lam SM,Cao M,et al.Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY[J].Redox Biol,2021,40:101855.DOI:10.1016/j.redox.2021.101855.
[36] Fendler W,Rizzo M,Borowiec M,et al.Less but better:cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level[J].Acta Diabetol,2014,51(4):625-632.DOI:10.1007/s00592-014-0567-1.
[37] Weng J,Zhou Z,Guo L,et al.Incidence of type 1 diabetes in China,2010-13:population based study[J].BMJ,2018,360:j5295.DOI:10.1136/bmj.j5295.
[38] Pedersen J.Diabetes and pregnancy; blood sugar of newborn infants during fasting and glucose administration[J].Nord Med,1952,47(30):1049.
[39] Spyer G,Macleod KM,Shepherd M,et al.Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation[J].Diabet Med,2009,26(1):14-18.DOI:10.1111/j.1464-5491.2008.02622.x.
[40] Spyer G,Hattersley AT,Sykes JE,et al.Influence of maternal and fetal glucokinase mutations in gestational diabetes[J].Am J Obstet Gynecol,2001,185(1):240-241.DOI:10.1067/mob.2001.113127.
[41] Ellard S,Bellanné-Chantelot C,Hattersley AT.Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young[J].Diabetologia,2008,51(4):546-553.DOI:10.1007/s00125-008-0942-y.
[42] Pinelli M,Acquaviva F,Barbetti F,et al.Identification of candidate children for maturity-onset diabetes of the young type 2(MODY2)gene testing:a seven-item clinical flowchart(7-iF)[J].PLoS One,2013,8(11):e79933.DOI:10.1371/journal.pone.0079933.
[43] Ma Y,Han X,Zhou X,et al.A new clinical screening strategy and prevalence estimation for glucokinase variant-induced diabetes in an adult Chinese population[J].Genet Med,2019,21(4):939-947.DOI:10.1038/s41436-018-0282-3.
[44] Liu Y,Xie Z,Sun X,et al.A new screening strategy and whole-exome sequencing for the early diagnosis of maturity-onset diabetes of the young[J].Diabetes Metab Res Rev,2021,37(5):e3381.DOI:10.1002/dmrr.3381.
[45] Diabetes Research Department and the Centre for Molecular Genetics at the University of Exeter Medical School and Royal Devon and Exeter Hospital,UK.Guidelines for genetic testing in MODY[EB/OL].[2019-03-27].https://www.diabetesgenes.org/tests-for-diabetes-subtypes/guidelines-for-genetic- testing-in-mody/.
[46] Stride A,Shields B,Gill-Carey O,et al.Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia[J].Diabetologia,2014,57(1):54-56.DOI:10.1007/s00125-013-3075-x.
[47] Shepherd MH,Shields BM,Hudson M,et al.A UK nationwide prospective study of treatment change in MODY:genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin[J].Diabetologia,2018,61(12):2520-2527.DOI:10.1007/s00125-018-4728-6.
[48] Schaefer-Graf UM,Kjos SL,Fauzan OH,et al.A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women[J].Diabetes Care,2004,27(2):297-302.DOI:10.2337/diacare.27.2.297.
[49] Kjos SL,Schaefer-Graf U,Sardesi S,et al.A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia[J].Diabetes Care,2001,24(11):1904-1910.DOI:10.2337/diacare.24.11.1904.
[50] Dickens LT,Letourneau LR,Sanyoura M,et al.Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry[J].Acta Diabetol,2019,56(4):405-411.DOI:10.1007/s00592-018-1267-z.
[51] Chakera AJ,Carleton VL,Ellard S,et al.Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment[J].Diabetes Care,2012,35(9):1832-1834.DOI:10.2337/dc12-0151.
[52] Chakera AJ,Carleton VL,Shields B,et al.Response to Comment on:Chakeraet al.Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment.Diabetes Care 2012; 35:1832-1834[J].Diabetes Care,2013,36(1):e15.DOI:10.2337/dc12-1497.